Four Things to Know About RSV, a Systematic Review of the Clinical Effectiveness of Tixagevimab/Cilgavimab for Prophylaxis of COVID-19 in Immunocompromised Patients, and Long-Lasting Symptoms After an Acute COVID-19 Infection and Factors Associated With Their Resolution

6 views
January 28, 2023
0 Comments
Login to view comments. Click here to Login